Preoperative imaging in primary hyperparathyroidism: Are 11C-Choline PET/CT and 99mTc-MIBI/123Iodide subtraction SPECT/CT interchangeable or do they supplement each other?
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Preoperative imaging in primary hyperparathyroidism : Are 11C-Choline PET/CT and 99mTc-MIBI/123Iodide subtraction SPECT/CT interchangeable or do they supplement each other? / Christensen, Julie W.; Ismail, Afefah; Søndergaard, Susanne B.; Bennedbæk, Finn N.; Nygaard, Birte; Jensen, Lars T.; Trolle, Waldemar; Holst-Hahn, Christoffer; Zerahn, Bo; Kristensen, Bent; Krakauer, Martin.
In: Clinical Endocrinology, Vol. 97, No. 3, 2022, p. 258–267.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Preoperative imaging in primary hyperparathyroidism
T2 - Are 11C-Choline PET/CT and 99mTc-MIBI/123Iodide subtraction SPECT/CT interchangeable or do they supplement each other?
AU - Christensen, Julie W.
AU - Ismail, Afefah
AU - Søndergaard, Susanne B.
AU - Bennedbæk, Finn N.
AU - Nygaard, Birte
AU - Jensen, Lars T.
AU - Trolle, Waldemar
AU - Holst-Hahn, Christoffer
AU - Zerahn, Bo
AU - Kristensen, Bent
AU - Krakauer, Martin
N1 - Publisher Copyright: © 2022 The Authors. Clinical Endocrinology published by John Wiley & Sons Ltd.
PY - 2022
Y1 - 2022
N2 - Objective: Preoperative location of hyperfunctioning parathyroid glands (HPGs) is vital when planning minimally invasive surgery in patients with primary hyperparathyroidism (PHPT). Dual-isotope subtraction scintigraphy with 99mTc-MIBI/123Iodide using SPECT/CT and planar pinhole imaging (Di-SPECT) has shown high sensitivity, but is challenged by high radiation dose, time consumption and cost. 11C-Choline PET/CT (faster with a lower radiation dose) is non-inferior to Di-SPECT. We aim to clarify to what extent the two are interchangeable and how often there are discrepancies. Design: This is a prospective, GCP-controlled cohort study. Patients and Measurements: One hundred patients diagnosed with PHPT were included and underwent both imaging modalities before parathyroidectomy. Clinical implications of differences between imaging findings and negative imaging results were assessed. Surgical findings confirmed by biochemistry and pathology served as reference standard. Results: Among the 90 patients cured by parathyroidectomy, sensitivity was 82% (95% confidence interval [CI]: 74%–88%) and 87% (95% CI: 79%–92%) for Choline PET and Di-SPECT, respectively, p =.88. In seven cases at least one imaging modality found no HPG. Of these, neither modality found any true HPGs and only two were cured by surgery. When a positive finding in one modality was incorrect, the alternative modality was correct in approximately half of the cases. Conclusion: Choline PET and Di-SPECT performed equally well and are both appropriate as first-line imaging modalities for preoperative imaging of PHPT. When the first-line modality fails to locate an HPG, additional preoperative imaging with the alternate modality offers no benefit. However, if parathyroidectomy is unsuccessful, additional imaging with the alternate modality has merit before repeat surgery.
AB - Objective: Preoperative location of hyperfunctioning parathyroid glands (HPGs) is vital when planning minimally invasive surgery in patients with primary hyperparathyroidism (PHPT). Dual-isotope subtraction scintigraphy with 99mTc-MIBI/123Iodide using SPECT/CT and planar pinhole imaging (Di-SPECT) has shown high sensitivity, but is challenged by high radiation dose, time consumption and cost. 11C-Choline PET/CT (faster with a lower radiation dose) is non-inferior to Di-SPECT. We aim to clarify to what extent the two are interchangeable and how often there are discrepancies. Design: This is a prospective, GCP-controlled cohort study. Patients and Measurements: One hundred patients diagnosed with PHPT were included and underwent both imaging modalities before parathyroidectomy. Clinical implications of differences between imaging findings and negative imaging results were assessed. Surgical findings confirmed by biochemistry and pathology served as reference standard. Results: Among the 90 patients cured by parathyroidectomy, sensitivity was 82% (95% confidence interval [CI]: 74%–88%) and 87% (95% CI: 79%–92%) for Choline PET and Di-SPECT, respectively, p =.88. In seven cases at least one imaging modality found no HPG. Of these, neither modality found any true HPGs and only two were cured by surgery. When a positive finding in one modality was incorrect, the alternative modality was correct in approximately half of the cases. Conclusion: Choline PET and Di-SPECT performed equally well and are both appropriate as first-line imaging modalities for preoperative imaging of PHPT. When the first-line modality fails to locate an HPG, additional preoperative imaging with the alternate modality offers no benefit. However, if parathyroidectomy is unsuccessful, additional imaging with the alternate modality has merit before repeat surgery.
KW - C-Choline PET/CT
KW - Tc-MIBI/Iodide subtraction SPECT/CT
KW - hyperparathyroidism
KW - method comparison
KW - parathyroidectomy
KW - preoperative imaging
KW - prospective cohort
U2 - 10.1111/cen.14688
DO - 10.1111/cen.14688
M3 - Journal article
C2 - 35150160
AN - SCOPUS:85125059957
VL - 97
SP - 258
EP - 267
JO - Clinical Endocrinology
JF - Clinical Endocrinology
SN - 0300-0664
IS - 3
ER -
ID: 314147936